VitalHub Expands Use of Award-Winning Synopsis Product to New Region with the Announcement of Licensing Deal in the Bahamas
TORONTO, Jan. 05, 2021 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) is pleased to announce a material licensing transaction of newly-acquired subsidiary Intouch with Health’s (“Intouch”) digital health platform to Anaesthesia Associates Medical Group (the “Group” or “AAMG”) in Nassau, Bahamas. This transaction marks the expansion of the Company’s award-winning Synopsis suite of solutions to the Caribbean region.
Anaesthesia Associates Medical Group is an independent anaesthesia group supporting four hospitals in the region. The Group has been aiming to undergo a meaningful digital transformation that will enable the integration of care systems across facilities to provide enhanced care delivery and patient outcomes. This contract serves to address AAMG’s need to support local hospitals in Nassau with a pre-operative assessment solution, providing their clinical group with an electronic record which is easily accessible, user-friendly, and underpinned with internationally recognized risk-scores.
With this deal, VitalHub is responding to the Group’s need to promote high quality, dynamic outpatient services which enable socially distanced care delivery. This transaction is the first for VitalHub in the area and represents the Company’s continued growth into various international markets.
The transition to a virtual clinic format will facilitate a reduction in AAMG’s requirement for patients to attend hospitals for consultations, improving capacity and load balancing, patient convenience, and the overall care delivery process. These improvements will also extend to long term care patients who will be proactively managed in their homes, affording improved levels of communication while reducing pressures on clinicians.
The Group has licensed award-winning Synopsis iQ, which will provide the ability to share comprehensive pre-operative information with another provider that allows them to care for that patient in a blended and seamless manner, managing, on the same integrated platform, those patients who present remotely for consultation alongside those who physical present at one of their hospital sites.
“The demand and needs addressed by Synopsis solution extend far beyond the UK marketplace, with applicability across health systems globally,” said Dan Matlow, CEO of VitalHub Corp. “We are seeing consistent demand and need for solutions that support the transition to virtual care, and the Synopsis iQ solution meets all the needs. We continue to work to expose other geographies to this solution, and this transaction demonstrates the potential success new channels will deliver as we continue to extend our reach and growth internationally.”
ABOUT VITALHUB
Software for Health and Human Services providers designed to simplify the user experience & optimize outcomes.
VitalHub provides technology to Health and Human Services providers including; Hospitals, Regional Health Authorities, Mental Health, Long Term Care, Home Health, Community and Social Services. VitalHub solutions span the categories of Electronic Health Record (EHR), Case Management, Care Coordination, Patient Flow & Operational Visibility, and DOCit Mobile Apps.
The Company has a robust two-pronged growth strategy, targeting organic growth opportunities within its product suite, and pursuing an aggressive M&A plan. Currently, VitalHub serves 275+ clients across Canada, USA, UK, Australia, Qatar, and Latvia. VitalHub is based in Toronto, Canada, with an offshore development hub in Sri Lanka. The Company is publicly traded on the TSX Venture Exchange under the symbol “VHI”.
CAUTIONARY STATEMENT
This press release includes forward-looking statements regarding the Corporation and its business, which may include, but is not limited to, statements with respect to the appointment of a new directors. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "is expected", "expects", "scheduled", "intends", "contemplates", "anticipates", "believes", "proposes" or variations (including negative variations) of such words and phrases, or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Such statements are based on the current expectations of the management of each entity and are based on assumptions and subject to risks and uncertainties. Although the management of each entity believes that the assumptions underlying these statements are reasonable, they may prove to be incorrect. The forward-looking events and circumstances discussed in this release, may not occur by certain specified dates or at all and could differ materially as a result of known and unknown risk factors and uncertainties affecting the companies, including risks regarding the technology industry, failure to obtain regulatory or shareholder approvals, market conditions, economic factors, the equity markets generally and risks associated with growth and competition. Although the Corporation has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. No forward-looking statement can be guaranteed. Except as required by applicable securities laws, forward-looking statements speak only as of the date on which they are made and the Corporation undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise.